Recombinant Protein Drug R & D Market, Global Outlook and Forecast 2023-2029

Report ID: MMG238390 | Category: Service & Software | Pages: 101 | Format: PDF | Published Date: September 16,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

This report aims to provide a comprehensive presentation of the global market for Recombinant Protein Drug R & D, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Protein Drug R & D. This report contains market size and forecasts of Recombinant Protein Drug R & D in global, including the following market information:
Global Recombinant Protein Drug R & D Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Recombinant Protein Drug R & D market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Peptide Hormones Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Recombinant Protein Drug R & D include Eli Lilly, Novo Nordisk, Amgen, Merck, Sanofi, Pfizer, Roche, Gensci and Ankebio, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Recombinant Protein Drug R & D companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Recombinant Protein Drug R & D Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Recombinant Protein Drug R & D Market Segment Percentages, by Type, 2022 (%)
    Peptide Hormones
    Hematopoietic Factor
    Cytokines
    Plasma Protein Factor
    Recombinase
    Fusion Protein
    Other
Global Recombinant Protein Drug R & D Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Recombinant Protein Drug R & D Market Segment Percentages, by Application, 2022 (%)
    Diabetes
    Dwarfism
    Hemophilia
    Heart Disease
    Cancer
    Other
Global Recombinant Protein Drug R & D Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Recombinant Protein Drug R & D Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Recombinant Protein Drug R & D revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Recombinant Protein Drug R & D revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Eli Lilly
    Novo Nordisk
    Amgen
    Merck
    Sanofi
    Pfizer
    Roche
    Gensci
    Ankebio
    United Cell
    Sinobioway Hygene
    Kexing
    Dongbao
    3sbio
    Gan&Lee
    Hengrui
Outline of Major Chapters:
Chapter 1: Introduces the definition of Recombinant Protein Drug R & D, market overview.
Chapter 2: Global Recombinant Protein Drug R & D market size in revenue.
Chapter 3: Detailed analysis of Recombinant Protein Drug R & D company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Recombinant Protein Drug R & D in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Recombinant Protein Drug R & D Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Recombinant Protein Drug R & D Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Recombinant Protein Drug R & D Overall Market Size
    2.1 Global Recombinant Protein Drug R & D Market Size: 2022 VS 2029
    2.2 Global Recombinant Protein Drug R & D Market Size, Prospects & Forecasts: 2018-2029
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Recombinant Protein Drug R & D Players in Global Market
    3.2 Top Global Recombinant Protein Drug R & D Companies Ranked by Revenue
    3.3 Global Recombinant Protein Drug R & D Revenue by Companies
    3.4 Top 3 and Top 5 Recombinant Protein Drug R & D Companies in Global Market, by Revenue in 2022
    3.5 Global Companies Recombinant Protein Drug R & D Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Recombinant Protein Drug R & D Players in Global Market
        3.6.1 List of Global Tier 1 Recombinant Protein Drug R & D Companies
        3.6.2 List of Global Tier 2 and Tier 3 Recombinant Protein Drug R & D Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Recombinant Protein Drug R & D Market Size Markets, 2022 & 2029
        4.1.2 Peptide Hormones
        4.1.3 Hematopoietic Factor
        4.1.4 Cytokines
        4.1.5 Plasma Protein Factor
        4.1.6 Recombinase
        4.1.7 Fusion Protein
        4.1.8 Other
    4.2 By Type - Global Recombinant Protein Drug R & D Revenue & Forecasts
        4.2.1 By Type - Global Recombinant Protein Drug R & D Revenue, 2018-2023
        4.2.2 By Type - Global Recombinant Protein Drug R & D Revenue, 2024-2029
        4.2.3 By Type - Global Recombinant Protein Drug R & D Revenue Market Share, 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Recombinant Protein Drug R & D Market Size, 2022 & 2029
        5.1.2 Diabetes
        5.1.3 Dwarfism
        5.1.4 Hemophilia
        5.1.5 Heart Disease
        5.1.6 Cancer
        5.1.7 Other
    5.2 By Application - Global Recombinant Protein Drug R & D Revenue & Forecasts
        5.2.1 By Application - Global Recombinant Protein Drug R & D Revenue, 2018-2023
        5.2.2 By Application - Global Recombinant Protein Drug R & D Revenue, 2024-2029
        5.2.3 By Application - Global Recombinant Protein Drug R & D Revenue Market Share, 2018-2029
6 Sights by Region
    6.1 By Region - Global Recombinant Protein Drug R & D Market Size, 2022 & 2029
    6.2 By Region - Global Recombinant Protein Drug R & D Revenue & Forecasts
        6.2.1 By Region - Global Recombinant Protein Drug R & D Revenue, 2018-2023
        6.2.2 By Region - Global Recombinant Protein Drug R & D Revenue, 2024-2029
        6.2.3 By Region - Global Recombinant Protein Drug R & D Revenue Market Share, 2018-2029
    6.3 North America
        6.3.1 By Country - North America Recombinant Protein Drug R & D Revenue, 2018-2029
        6.3.2 US Recombinant Protein Drug R & D Market Size, 2018-2029
        6.3.3 Canada Recombinant Protein Drug R & D Market Size, 2018-2029
        6.3.4 Mexico Recombinant Protein Drug R & D Market Size, 2018-2029
    6.4 Europe
        6.4.1 By Country - Europe Recombinant Protein Drug R & D Revenue, 2018-2029
        6.4.2 Germany Recombinant Protein Drug R & D Market Size, 2018-2029
        6.4.3 France Recombinant Protein Drug R & D Market Size, 2018-2029
        6.4.4 U.K. Recombinant Protein Drug R & D Market Size, 2018-2029
        6.4.5 Italy Recombinant Protein Drug R & D Market Size, 2018-2029
        6.4.6 Russia Recombinant Protein Drug R & D Market Size, 2018-2029
        6.4.7 Nordic Countries Recombinant Protein Drug R & D Market Size, 2018-2029
        6.4.8 Benelux Recombinant Protein Drug R & D Market Size, 2018-2029
    6.5 Asia
        6.5.1 By Region - Asia Recombinant Protein Drug R & D Revenue, 2018-2029
        6.5.2 China Recombinant Protein Drug R & D Market Size, 2018-2029
        6.5.3 Japan Recombinant Protein Drug R & D Market Size, 2018-2029
        6.5.4 South Korea Recombinant Protein Drug R & D Market Size, 2018-2029
        6.5.5 Southeast Asia Recombinant Protein Drug R & D Market Size, 2018-2029
        6.5.6 India Recombinant Protein Drug R & D Market Size, 2018-2029
    6.6 South America
        6.6.1 By Country - South America Recombinant Protein Drug R & D Revenue, 2018-2029
        6.6.2 Brazil Recombinant Protein Drug R & D Market Size, 2018-2029
        6.6.3 Argentina Recombinant Protein Drug R & D Market Size, 2018-2029
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Recombinant Protein Drug R & D Revenue, 2018-2029
        6.7.2 Turkey Recombinant Protein Drug R & D Market Size, 2018-2029
        6.7.3 Israel Recombinant Protein Drug R & D Market Size, 2018-2029
        6.7.4 Saudi Arabia Recombinant Protein Drug R & D Market Size, 2018-2029
        6.7.5 UAE Recombinant Protein Drug R & D Market Size, 2018-2029
7 Recombinant Protein Drug R & D Companies Profiles
    7.1 Eli Lilly
        7.1.1 Eli Lilly Company Summary
        7.1.2 Eli Lilly Business Overview
        7.1.3 Eli Lilly Recombinant Protein Drug R & D Major Product Offerings
        7.1.4 Eli Lilly Recombinant Protein Drug R & D Revenue in Global Market (2018-2023)
        7.1.5 Eli Lilly Key News & Latest Developments
    7.2 Novo Nordisk
        7.2.1 Novo Nordisk Company Summary
        7.2.2 Novo Nordisk Business Overview
        7.2.3 Novo Nordisk Recombinant Protein Drug R & D Major Product Offerings
        7.2.4 Novo Nordisk Recombinant Protein Drug R & D Revenue in Global Market (2018-2023)
        7.2.5 Novo Nordisk Key News & Latest Developments
    7.3 Amgen
        7.3.1 Amgen Company Summary
        7.3.2 Amgen Business Overview
        7.3.3 Amgen Recombinant Protein Drug R & D Major Product Offerings
        7.3.4 Amgen Recombinant Protein Drug R & D Revenue in Global Market (2018-2023)
        7.3.5 Amgen Key News & Latest Developments
    7.4 Merck
        7.4.1 Merck Company Summary
        7.4.2 Merck Business Overview
        7.4.3 Merck Recombinant Protein Drug R & D Major Product Offerings
        7.4.4 Merck Recombinant Protein Drug R & D Revenue in Global Market (2018-2023)
        7.4.5 Merck Key News & Latest Developments
    7.5 Sanofi
        7.5.1 Sanofi Company Summary
        7.5.2 Sanofi Business Overview
        7.5.3 Sanofi Recombinant Protein Drug R & D Major Product Offerings
        7.5.4 Sanofi Recombinant Protein Drug R & D Revenue in Global Market (2018-2023)
        7.5.5 Sanofi Key News & Latest Developments
    7.6 Pfizer
        7.6.1 Pfizer Company Summary
        7.6.2 Pfizer Business Overview
        7.6.3 Pfizer Recombinant Protein Drug R & D Major Product Offerings
        7.6.4 Pfizer Recombinant Protein Drug R & D Revenue in Global Market (2018-2023)
        7.6.5 Pfizer Key News & Latest Developments
    7.7 Roche
        7.7.1 Roche Company Summary
        7.7.2 Roche Business Overview
        7.7.3 Roche Recombinant Protein Drug R & D Major Product Offerings
        7.7.4 Roche Recombinant Protein Drug R & D Revenue in Global Market (2018-2023)
        7.7.5 Roche Key News & Latest Developments
    7.8 Gensci
        7.8.1 Gensci Company Summary
        7.8.2 Gensci Business Overview
        7.8.3 Gensci Recombinant Protein Drug R & D Major Product Offerings
        7.8.4 Gensci Recombinant Protein Drug R & D Revenue in Global Market (2018-2023)
        7.8.5 Gensci Key News & Latest Developments
    7.9 Ankebio
        7.9.1 Ankebio Company Summary
        7.9.2 Ankebio Business Overview
        7.9.3 Ankebio Recombinant Protein Drug R & D Major Product Offerings
        7.9.4 Ankebio Recombinant Protein Drug R & D Revenue in Global Market (2018-2023)
        7.9.5 Ankebio Key News & Latest Developments
    7.10 United Cell
        7.10.1 United Cell Company Summary
        7.10.2 United Cell Business Overview
        7.10.3 United Cell Recombinant Protein Drug R & D Major Product Offerings
        7.10.4 United Cell Recombinant Protein Drug R & D Revenue in Global Market (2018-2023)
        7.10.5 United Cell Key News & Latest Developments
    7.11 Sinobioway Hygene
        7.11.1 Sinobioway Hygene Company Summary
        7.11.2 Sinobioway Hygene Business Overview
        7.11.3 Sinobioway Hygene Recombinant Protein Drug R & D Major Product Offerings
        7.11.4 Sinobioway Hygene Recombinant Protein Drug R & D Revenue in Global Market (2018-2023)
        7.11.5 Sinobioway Hygene Key News & Latest Developments
    7.12 Kexing
        7.12.1 Kexing Company Summary
        7.12.2 Kexing Business Overview
        7.12.3 Kexing Recombinant Protein Drug R & D Major Product Offerings
        7.12.4 Kexing Recombinant Protein Drug R & D Revenue in Global Market (2018-2023)
        7.12.5 Kexing Key News & Latest Developments
    7.13 Dongbao
        7.13.1 Dongbao Company Summary
        7.13.2 Dongbao Business Overview
        7.13.3 Dongbao Recombinant Protein Drug R & D Major Product Offerings
        7.13.4 Dongbao Recombinant Protein Drug R & D Revenue in Global Market (2018-2023)
        7.13.5 Dongbao Key News & Latest Developments
    7.14 3sbio
        7.14.1 3sbio Company Summary
        7.14.2 3sbio Business Overview
        7.14.3 3sbio Recombinant Protein Drug R & D Major Product Offerings
        7.14.4 3sbio Recombinant Protein Drug R & D Revenue in Global Market (2018-2023)
        7.14.5 3sbio Key News & Latest Developments
    7.15 Gan&Lee
        7.15.1 Gan&Lee Company Summary
        7.15.2 Gan&Lee Business Overview
        7.15.3 Gan&Lee Recombinant Protein Drug R & D Major Product Offerings
        7.15.4 Gan&Lee Recombinant Protein Drug R & D Revenue in Global Market (2018-2023)
        7.15.5 Gan&Lee Key News & Latest Developments
    7.16 Hengrui
        7.16.1 Hengrui Company Summary
        7.16.2 Hengrui Business Overview
        7.16.3 Hengrui Recombinant Protein Drug R & D Major Product Offerings
        7.16.4 Hengrui Recombinant Protein Drug R & D Revenue in Global Market (2018-2023)
        7.16.5 Hengrui Key News & Latest Developments
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Recombinant Protein Drug R & D Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?